Neuroprotective Therapy Company Quethera Reveals Gene Therapy Results at ARVO
Quethera, a biopharmaceutical company developing therapies for ocular disorders, today presented strong efficacy...
read moreThe Fund’s investment criteria which must be met for us to invest are:
1. Projects and companies arise from world-class research carried out in our partner laboratories across the UK, including those at Rutherford Appleton Laboratory (STFC), Babraham Institute (BBSRC) and Porton Down (Dstl).
OR
2. Companies are based at or relocating to our partners’ national science and innovation campuses in Harwell Oxford, Babraham Cambridge, Daresbury Warrington and Norwich.
3. UK Companies working in the field of synthetic biology: Synthetic biology is an exciting new discipline based on the design and engineering of biologically-based parts, novel devices and systems and the redesign of existing, natural biological systems.
Quethera, a biopharmaceutical company developing therapies for ocular disorders, today presented strong efficacy...
read moreNemesis Bioscience today announced the successful completion of its latest funding round, bringing total...
read more